Gene: ABCA3
Official Full Name: ATP binding cassette subfamily A member 3provided by HGNC
Gene Summary: The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03209 | ABCA3 Knockout cell line (HeLa) | Human | ABCA3 | 1:3~1:6 | Negative | Online Inquiry |
KO03210 | ABCA3 Knockout cell line (HCT 116) | Human | ABCA3 | 1:2~1:4 | Negative | Online Inquiry |
KO03211 | ABCA3 Knockout cell line (HEK293) | Human | ABCA3 | 1:3~1:6 | Negative | Online Inquiry |
KO03212 | ABCA3 Knockout cell line (A549) | Human | ABCA3 | 1:3~1:4 | Negative | Online Inquiry |
ABCA3 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the ATP-binding cassette (ABC) transporter family, specifically the ABCA3 gene, implicated in lipid metabolism and surfactant homeostasis. These cell lines have been genetically engineered to disable the ABCA3 gene, allowing researchers to observe the consequent biological effects on cellular function, particularly in the context of pulmonary physiology and pathology.
The primary function of ABCA3 involves the transport of lipids within alveolar epithelial cells, critical for the production and secretion of pulmonary surfactant. By toggling this gene, scientists can elucidate the underlying mechanisms of diseases such as surfactant deficiency, which can lead to severe respiratory complications. The gene knockout effectively models conditions where ABCA3 is dysfunctional, providing insights into its role in congenital respiratory disorders, potential drug target identification, and the impacts on cell signaling pathways.
From a scientific standpoint, these cell lines are invaluable in both research and clinical applications. They allow for in-depth mechanistic studies and drug screening, which are crucial for developing effective treatments for lung diseases associated with impaired surfactant function. Furthermore, in comparison to traditional knockdown approaches, knockout cell lines provide a more stable and definitive model for long-term studies.
The unique selling points of ABCA3 Gene Knockout Cell Lines include their robust genetic validity, consistent performance in assays, and the ability to provide a clear understanding of gene function without the confounding effects of residual expression. By utilizing these models, researchers can save time and resources, enhancing throughput in their experimental setups.
For researchers, clinicians, and pharmaceutical developers working on lung-related pathologies, these cell lines represent a pivotal tool in accelerating translational research. Our company specializes in the development of high-fidelity biological products, ensuring that our ABCA3 Gene Knockout Cell Lines meet the rigorous standards needed for impactful scientific discovery and application.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.